A study exploring immune response to electroconvulsive therapy and its impact on white matter microstructure of the brain.
This study aims to explore practice, use, and risk of electroconvulsive therapy (ECT) in pregnancy.
A response to yet another defence of ECT in the absence of robust efficacy and safety evidence by Professor John Read
ECT Device Safety - New York Association of Psychiatric Rehabilitation Services (NYAPRS) to the FDA, 2010
Vision disturbance is an ECT side effect few know about. Learn about this serious adverse event and what treatments are available.
Many barriers keep people harmed by ECT from reporting their injuries to the FDA. This comprehensive guide explains what adverse medical event reporting is and walks you through the process.